Barcelona, Spain

Ernest Giralt

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernest Giralt. Retrieved from https://idiyas.com/inventor/ernest-giralt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ernest Giralt

Introduction

Ernest Giralt is a prominent inventor based in Barcelona, Spain. He is known for his contributions to the field of biochemistry, particularly in the development of compounds with significant biological activity. His work has led to advancements in medicinal chemistry and drug development.

Latest Patents

One of Giralt's notable patents is for Kahalalide F and related compounds. This patent describes a process for preparing kahalalide F, which leads to the creation of other kahalalide mimic compounds that exhibit useful biological activity. This innovation has the potential to impact various therapeutic applications.

Career Highlights

Ernest Giralt has made significant strides in his career, particularly through his association with Pharma Mar, S.A. His expertise in biochemistry and drug development has positioned him as a key figure in the pharmaceutical industry. He holds 1 patent that showcases his innovative approach to solving complex biological challenges.

Collaborations

Throughout his career, Giralt has collaborated with esteemed colleagues such as Fernando Albericio and Jose Carlos Jimenez. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Ernest Giralt's contributions to the field of biochemistry and his innovative patent for Kahalalide F highlight his role as a significant inventor in the pharmaceutical industry. His work continues to inspire advancements in drug development and biological research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…